A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected,
about
A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected,
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Phase IIb Study to Evaluate ...... Virus Type 1 (HIV-1) Infected,
@en
A Phase IIb Study to Evaluate ...... Virus Type 1 (HIV-1) Infected,
@nl
type
label
A Phase IIb Study to Evaluate ...... Virus Type 1 (HIV-1) Infected,
@en
A Phase IIb Study to Evaluate ...... Virus Type 1 (HIV-1) Infected,
@nl
prefLabel
A Phase IIb Study to Evaluate ...... Virus Type 1 (HIV-1) Infected,
@en
A Phase IIb Study to Evaluate ...... Virus Type 1 (HIV-1) Infected,
@nl
P17
P1476
A Phase IIb Study Evaluating a ...... l Therapy-Naive Adult Subjects
@en
P3098
NCT02120352
P4844
P580
2014-04-28T00:00:00Z
P582
2015-08-13T00:00:00Z